NO763820L - - Google Patents

Info

Publication number
NO763820L
NO763820L NO763820A NO763820A NO763820L NO 763820 L NO763820 L NO 763820L NO 763820 A NO763820 A NO 763820A NO 763820 A NO763820 A NO 763820A NO 763820 L NO763820 L NO 763820L
Authority
NO
Norway
Application number
NO763820A
Other languages
Norwegian (no)
Other versions
NO144927B (no
NO144927C (no
Inventor
S Cohen
A Fisher
Original Assignee
Mundipharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mundipharma Ag filed Critical Mundipharma Ag
Publication of NO763820L publication Critical patent/NO763820L/no
Publication of NO144927B publication Critical patent/NO144927B/no
Publication of NO144927C publication Critical patent/NO144927C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/18—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Ophthalmology & Optometry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO763820A 1975-11-11 1976-11-10 Analogifremgangsmaate ved fremstilling av terapeutisk aktive kinuclidinderivater NO144927C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL48453A IL48453A (en) 1975-11-11 1975-11-11 Substituted 6-oxa-1-azatricyclo-(6.2.2.0 )dodecan-5-ones and 1,4-ethano-5-oxo octa (or decahydro)quinoline,their preparation and pharmaceutical compositions containing them

Publications (3)

Publication Number Publication Date
NO763820L true NO763820L (enExample) 1977-05-12
NO144927B NO144927B (no) 1981-08-31
NO144927C NO144927C (no) 1981-12-09

Family

ID=11048546

Family Applications (1)

Application Number Title Priority Date Filing Date
NO763820A NO144927C (no) 1975-11-11 1976-11-10 Analogifremgangsmaate ved fremstilling av terapeutisk aktive kinuclidinderivater

Country Status (22)

Country Link
US (1) US4083985A (enExample)
JP (2) JPS6045198B2 (enExample)
AR (1) AR213184A1 (enExample)
AT (1) AT355035B (enExample)
AU (1) AU511347B2 (enExample)
BE (1) BE848227A (enExample)
CA (1) CA1078385A (enExample)
CH (2) CH635102A5 (enExample)
DE (1) DE2650876A1 (enExample)
DK (1) DK507376A (enExample)
ES (1) ES453162A1 (enExample)
FI (1) FI60013C (enExample)
FR (1) FR2331339A1 (enExample)
GB (1) GB1571511A (enExample)
IL (1) IL48453A (enExample)
IN (1) IN145202B (enExample)
MX (1) MX4767E (enExample)
NL (1) NL7612427A (enExample)
NO (1) NO144927C (enExample)
NZ (1) NZ182556A (enExample)
SE (1) SE435929B (enExample)
ZA (1) ZA766663B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4183938A (en) * 1975-11-11 1980-01-15 The Purdue Frederick Company 1,8-Ethano-5-oxo-octa- and -decahydroquinolines and mydriatic compositions thereof
US4855290A (en) 1985-05-10 1989-08-08 State Of Israel, Represented By Prime Minister's Office, Israel Institute For Biological Research Derivatives of quinuclidine
US4876260A (en) * 1987-10-28 1989-10-24 State Of Israel, Israel Institute Of Biological Research Oxathiolanes
US5852029A (en) * 1990-04-10 1998-12-22 Israel Institute For Biological Research Aza spiro compounds acting on the cholinergic system with muscarinic agonist activity
US5407938A (en) * 1990-04-10 1995-04-18 Israel Institute For Biological Research Certain 1-methyl-piperidine-4-spiro-4'-(1'-3'-oxazolines) and corresponding -(1',3' thiazolines)
JPH0518551U (ja) * 1991-08-28 1993-03-09 亀吉 立花 ぶら下がり健康器
US5280028A (en) * 1992-06-24 1994-01-18 G. D. Searle & Co. Benzimidazole compounds
US5521193A (en) * 1992-06-24 1996-05-28 G. D. Searle & Co. Benzimidazole compounds
US5534521A (en) * 1993-06-23 1996-07-09 G. D. Searle & Co. Benzimidazole compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3857837A (en) * 1968-07-02 1974-12-31 Hoffmann La Roche Processes and intermediated for quinine, quinidine, isomers and derivatives thereof

Also Published As

Publication number Publication date
FR2331339A1 (fr) 1977-06-10
JPS6045198B2 (ja) 1985-10-08
JPS5283396A (en) 1977-07-12
US4083985A (en) 1978-04-11
FR2331339B1 (enExample) 1980-04-04
AU511347B2 (en) 1980-08-14
IN145202B (enExample) 1978-09-09
JPS6043348B2 (ja) 1985-09-27
NO144927B (no) 1981-08-31
FI60013C (fi) 1981-11-10
AR213184A1 (es) 1978-12-29
AT355035B (de) 1980-02-11
AU1955276A (en) 1978-05-18
NL7612427A (nl) 1977-05-13
JPS60120876A (ja) 1985-06-28
CH640234A5 (de) 1983-12-30
CA1078385A (en) 1980-05-27
GB1571511A (en) 1980-07-16
SE435929B (sv) 1984-10-29
IL48453A (en) 1980-06-30
CH635102A5 (de) 1983-03-15
ES453162A1 (es) 1977-11-01
SE8003351L (sv) 1980-05-05
NZ182556A (en) 1979-10-25
BE848227A (fr) 1977-03-01
ATA839476A (de) 1979-07-15
FI60013B (fi) 1981-07-31
FI763152A7 (enExample) 1977-05-12
NO144927C (no) 1981-12-09
MX4767E (es) 1982-09-08
DE2650876A1 (de) 1977-05-18
IL48453A0 (en) 1976-01-30
DK507376A (da) 1977-05-12
ZA766663B (en) 1977-10-26

Similar Documents

Publication Publication Date Title
FR2325509B1 (enExample)
FR2331339B1 (enExample)
FR2336369B1 (enExample)
JPS5333918Y2 (enExample)
JPS5277068U (enExample)
JPS5342515Y2 (enExample)
JPS5649541Y2 (enExample)
JPS5135229Y1 (enExample)
JPS51129741U (enExample)
JPS51127538U (enExample)
JPS51152997U (enExample)
BG23066A1 (enExample)
CH608418A5 (enExample)
CH596331A5 (enExample)
CH608738A5 (enExample)
CH596119A5 (enExample)
CH1020375A4 (enExample)
CH605665A5 (enExample)
CH600083A5 (enExample)
CH588401A5 (enExample)
CH597036A5 (enExample)
CH597750A5 (enExample)
CH581241A5 (enExample)
BG22168A1 (enExample)
CH604739A5 (enExample)